title: Spectral karyotyping of the human colon cancer cell lines SW480 and SW620.
abstract: The cell lines SW480 and SW620, derived from different stages of colon carcinoma in the same patient, have been used for a number of biochemical, immunological, and genetic studies on colon cancer. A comparative analysis of their karyotypes may identify chromosomal aberrations that might represent markers for metastatic spread. In the present study spectral karyotyping (SKY) was applied to these two colon cancer cell lines. Compared to previously reported G-banded karyotypes, 9 (SW480) and 7 (SW620) markers were identical, 3 (SW480) and 3 (SW620) markers could be redefined, 5 (SW480) and 8 (SW620) markers were newly identified, and 4 (SW480) and 5 (SW620) of the previous described markers could not be confirmed. The redefined aberrations include very complex rearrangements, such as a der(16) t(3;16;1;16;8;16; 1;16;10) and a der(18)t(18;15;17)(q12; p11p13;??) in SW620 and a der(19)t(19;8;19;5) in SW480, that have not been identified by conventional banding techniques. The resulting chromosome gains (5q11-->5q15, 7pter-->q22, 11, 13q14-->qter, 20pter-->p12, X) and losses (8pter-->p2, 18q12-->qter, Y) found in both SW480 and SW620 were in good agreement with those frequently described in colorectal tumors as primary changes in the stem cell. Abnormalities found exclusively in SW620 cells only (gains of 5pter-->5q11, 12q12-->q23, 15p13-->p11, and 16q21-->q24 and losses of 2pter-->2p24, 4q28-->qter, and 6q25-->qter) can be viewed as changes that occurred in a putative metastatic founder cell.
authors.affiliation: Institute of Human Genetics, University of Würzburg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Melcher
authors.forename: C
authors.initials: C
authors.lastname: Steinlein
authors.forename: W
authors.initials: W
authors.lastname: Feichtinger
authors.forename: C R
authors.initials: CR
authors.lastname: Müller
authors.forename: T
authors.initials: T
authors.lastname: Menzel
authors.forename: H
authors.initials: H
authors.lastname: Lührs
authors.forename: W
authors.initials: W
authors.lastname: Scheppach
authors.forename: M
authors.initials: M
authors.lastname: Schmid
mesh_terms: D000008:Abdominal Neoplasms / Q000235:genetics* / Q000473:pathology / Q000556:secondary*; D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology / Q000556:secondary*; D002869:Chromosome Aberrations / Q000235:genetics*; D002871:Chromosome Banding; D019457:Chromosome Breakage / Q000235:genetics; D002872:Chromosome Deletion; D003110:Colonic Neoplasms / Q000235:genetics* / Q000473:pathology; D005784:Gene Amplification / Q000235:genetics; D020440:Gene Duplication; D005819:Genetic Markers / Q000235:genetics; D006801:Humans; D007621:Karyotyping; D008297:Male; D009367:Neoplasm Staging; D009857:Oncogenes / Q000235:genetics; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics; D014178:Translocation, Genetic / Q000235:genetics; D014407:Tumor Cells, Cultured
chemical_list: D005819:Genetic Markers; D020794:Receptor Protein-Tyrosine Kinases; C084944:TYRO3 protein, human